JW Lifescience Corporation (KRX: 234080)

JW Lifescience Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	48,613	20,222	3,920	4,923	2,592	9,861
Short-Term Investments	7,110	8,126	24,953	155.05	-	-
Cash & Short-Term Investments	55,723	28,348	28,873	5,078	2,592	9,861
Cash Growth	115.74%	-1.82%	468.59%	95.88%	-73.71%	-22.82%
Accounts Receivable	39,561	55,505	53,426	32,141	34,716	33,888
Other Receivables	208.76	252.42	346.01	257.79	161.45	131.27
Receivables	44,270	55,757	53,772	37,198	36,578	34,019
Inventory	22,933	23,399	22,067	21,077	16,786	15,777
Prepaid Expenses	788.85	24.78	236.47	1,044	505.8	18.88
Other Current Assets	331	305.56	60.7	32.79	34.08	179.91
Total Current Assets	124,046	107,834	105,008	64,430	56,496	59,856
Property, Plant & Equipment	118,975	124,577	131,555	137,145	135,423	131,690
Long-Term Investments	8,240	10,419	4,390	8,934	13,097	518.87
Goodwill	950.99	950.99	950.99	950.99	950.99	950.99
Other Intangible Assets	2,711	2,870	3,100	3,671	3,916	3,834
Long-Term Deferred Tax Assets	14.72	15.81	-	-	-	-
Long-Term Deferred Charges	262.89	305.14	484.8	689.12	893.45	1,147
Other Long-Term Assets	6,698	8,865	7,453	3,646	3,626	3,408
Total Assets	261,899	255,836	252,942	219,467	214,402	201,404
Accounts Payable	14,518	18,740	15,118	12,496	10,714	11,263
Accrued Expenses	586.59	1,271	1,156	724.7	655.62	844.37
Short-Term Debt	15,700	15,700	36,681	44,350	32,000	34,040
Current Portion of Long-Term Debt	252	30,353	336	336	2,817	5,000
Current Portion of Leases	78.56	44.91	131.02	159.77	147.67	200.53
Current Income Taxes Payable	4,402	2,739	3,645	3,279	6,200	3,874
Other Current Liabilities	23,955	25,411	22,976	22,557	16,734	11,649
Total Current Liabilities	59,491	94,259	80,044	83,902	69,268	66,871
Long-Term Debt	28,635	168	30,007	1,610	1,512	5,430
Long-Term Leases	75.26	46.68	40.42	31.91	60.65	37.27
Long-Term Deferred Tax Liabilities	1,507	1,828	2,011	2,243	3,305	4,897
Other Long-Term Liabilities	1,987	141.95	508.07	187.8	7,762	711.2
Total Liabilities	91,696	96,443	112,610	87,975	81,908	78,788
Common Stock	39,586	39,586	39,586	39,586	39,586	39,586
Additional Paid-In Capital	28,335	28,335	28,335	28,335	28,335	28,335
Retained Earnings	109,030	98,220	79,160	70,319	64,572	54,694
Treasury Stock	-6,749	-6,749	-6,749	-6,749	-	-
Comprehensive Income & Other	0	0	0	0	-	-
Shareholders' Equity	170,203	159,393	140,332	131,492	132,494	122,615
Total Liabilities & Equity	261,899	255,836	252,942	219,467	214,402	201,404
Total Debt	44,741	46,313	67,195	46,488	36,537	44,707
Net Cash (Debt)	10,982	-17,965	-38,322	-41,410	-33,945	-34,846
Net Cash Per Share	709.24	-1160.20	-2474.87	-2657.82	-2143.72	-2200.64
Filing Date Shares Outstanding	15.48	15.48	15.48	15.48	15.83	15.83
Total Common Shares Outstanding	15.48	15.48	15.48	15.48	15.83	15.83
Working Capital	64,555	13,574	24,965	-19,472	-12,772	-7,015
Book Value Per Share	10991.78	10293.69	9062.74	8491.82	8367.39	7743.54
Tangible Book Value	166,541	155,573	136,281	126,870	127,627	117,831
Tangible Book Value Per Share	10755.29	10046.95	8801.12	8193.30	8060.01	7441.37
Land	32,459	32,459	32,459	32,459	32,459	31,989
Buildings	37,429	39,820	41,648	42,618	44,529	46,781
Machinery	47,994	51,450	56,836	44,976	46,086	45,238
Construction In Progress	942.5	758.47	440.73	16,903	12,143	7,441

Source: S&P Capital IQ. Standard template. Financial Sources.